Device Devices

Gore Tag Thoracic Endoprosthesis

Payments companies reported to CMS as associated with Gore Tag Thoracic Endoprosthesis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$527Kassociated payments (2023-2025)
933clinicians with associated payments
1company reporting

By year

2023 $354K
2024 $170K
2025 $3,518

Payments reported as associated with Gore Tag Thoracic Endoprosthesis, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular Surgery $317K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $140K
Surgery $33K
Vascular & Interventional Radiology $9,979
Diagnostic Radiology $6,871
Cardiovascular Disease $4,884

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Gore Tag Thoracic Endoprosthesis

These are the largest totals companies reported as associated with Gore Tag Thoracic Endoprosthesis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Evan Brownie Murray, UT Vascular Surgery $20,352.64
Marvin Atkins Sugar Land, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $19,366.66
Joseph Bavaria Allentown, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) $18,704.21
Amelia Watkins Palo Alto, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $11,472.25
Luis Sanchez Saint Louis, MO Vascular Surgery $9,311.38
Takao Ohki Lake Success, NY Vascular Surgery $7,817.09
Joel Barbato Saint Paul, MN Vascular Surgery $5,729.25
Shahab Toursavadkohi Baltimore, MD Vascular Surgery $3,697.87
Michael Dake Stanford, CA Diagnostic Radiology $3,130.24
Edward Percy Philadelphia, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,029.16

Prescribed Gore Tag Thoracic Endoprosthesis?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.